Nxera Pharma Co Ltd (SOLTF)
9.304
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Nxera Pharma Profit Margin (Quarterly): -2.85% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.85% |
| September 30, 2023 | -148.0% |
| June 30, 2023 | -54.70% |
| March 31, 2023 | -148.7% |
| December 31, 2022 | 52.06% |
| September 30, 2022 | 5.06% |
| June 30, 2022 | -109.7% |
| March 31, 2022 | -185.0% |
| December 31, 2021 | 20.12% |
| September 30, 2021 | |
| June 30, 2021 | -59.71% |
| March 31, 2021 | -95.53% |
| December 31, 2020 | 70.95% |
| September 30, 2020 | 24.65% |
| June 30, 2020 | -101.3% |
| March 31, 2020 | -64.20% |
| December 31, 2019 | -1.48% |
| September 30, 2019 | 39.28% |
| June 30, 2019 | -32.41% |
| March 31, 2019 | 32.46% |
| December 31, 2018 | -247.9% |
| September 30, 2018 | -213.7% |
| June 30, 2018 | -187.8% |
| March 31, 2018 | -138.8% |
| December 31, 2017 | -126.2% |
| Date | Value |
|---|---|
| September 30, 2017 | -38.36% |
| June 30, 2017 | 10.45% |
| March 31, 2017 | -50.25% |
| December 31, 2016 | 1.64% |
| September 30, 2016 | -66.67% |
| June 30, 2016 | 73.58% |
| March 31, 2016 | -887.1% |
| December 31, 2015 | 62.81% |
| September 30, 2015 | -10.08% |
| June 30, 2015 | -169.7% |
| March 31, 2015 | 9.12% |
| December 31, 2014 | 60.52% |
| September 30, 2014 | 40.12% |
| June 30, 2014 | -44.07% |
| March 31, 2014 | |
| December 31, 2013 | 28.52% |
| September 30, 2013 | 73.50% |
| June 30, 2013 | -317.3% |
| March 31, 2013 | |
| December 31, 2012 | -3.34% |
| September 30, 2012 | 46.79% |
| June 30, 2012 | -320.7% |
| March 31, 2012 | -2.08K% |
| December 31, 2011 | -2.07K% |
| September 30, 2011 | -39.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-185.0%
Minimum
Mar 2022
70.95%
Maximum
Dec 2020
-43.97%
Average
-43.55%
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 9.51% |
| PeptiDream Inc | -8.20% |
| Stemcell Holdings Inc | -- |
| Healios KK | -24.73K% |
| AnGes Inc | -5.24K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -11.71% |
| Return on Assets | -5.88% |
| Return on Invested Capital | -6.81% |
| Gross Profit Margin (Quarterly) | 76.00% |
| Operating Margin (Quarterly) | -21.04% |
| Return on Net Operating Assets | -12.64% |